SABS
#3364
SAB Biotherapeutics, Inc. - Common Stock
2.8 4 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.35%
Variación mensual
-16.96%
Variación en los últimos 6 meses
-28.10%
Cambio anual
+24.02%
Cierres anteriores
2.8 3
Open
2.8 4
Mínimo
2.8 0
Máximo
2.8 8
Financials
- Market Capitalization 258.4 M
- Employee 86
- Founded 2014
- CEO N/A
- Website www.sab.bio
- Headquarter Delaware, United States
- FIGI BBG00YHY0G24
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.73
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3341 |  ABEO Abeona Therapeutics Inc. - Common Stock | 4.64 USD | -5.31% | -8.30% | -14.23% | -12.95% | 265.33 M USD | ||
| 3353 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 2.06 USD | -5.07% | +6.19% | +103.96% | +126.37% | 262.15 M USD | ||
| 3371 |  RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 2.32 USD | -6.45% | -7.94% | -29.48% | -40.82% | 254.68 M USD | ||
| 3373 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 1.82 USD | -1.62% | -9.90% | -22.22% | +15.19% | 253.96 M USD |